Higher doses of topical corticosteroids, which are commonly used to treat inflammatory skin conditions, can elevate risks of osteoporosis and bone fractures associated with osteoporosis, indicates a new research.

Systemic corticosteroids are known to interfere with bone remodelling and increase osteoporosis and fracture risk, but evidence on the topical corticosteroids on bone health has been inconclusive.